U.S. Medical Glove Company (USMGC) — an American manufacturer of machines, components, and chemicals necessary to make nitrile and polyisoprene exam gloves — announced today a new contract worth $80 million.
The agreement is a joint venture partnership with Medeco Protective Safety Equipment Manufacturing — a division of Abu Dhabi Medical Devices Company (ADMD) in the United Arab Emirates — and contracts USMGC to manufacture 12 of its proprietary medical exam glove-making machines. Beginning in the first quarter of 2025, USMGC will deliver 10 nitrile exam glove machine lines and two polyisoprene surgical glove machine lines to Medeco facilities in operation in Saudi Arabia. The joint venture is structured for USMGC to retain a 25% ownership stake.
In the past year, USMGC has added several new operating units to the Harvard facility, including CNC machinery, fiber lasers, control panels, robotic glove-removal and glove-layering machine manufacturing, and one of the largest robotic welding units in the Midwest.
This new $80 million contract represents the second phase of a multi-year partnership between USMGC and ADMD. Completed earlier in 2024, phase one saw USMGC deliver two machine lines to ADMD's facilities in the United Arab Emirates. Phase two adds not only new machines lines and additional capacity, but also the strategic location of Medeco's facilities in Saudi Arabia. Currently, plans for the third and final phase of the joint venture include an expansion to 100 machine lines in Saudi Arabia and UAE serving national healthcare program facilities across American-allied nations in the Cooperation Council for the Arab States of the Gulf (GCC).
In addition to the machines, USMGC will supply Medeco with the raw NBR nitrile and polyisoprene required to manufacture medical exam and surgical gloves, in a partnership with U.S. Medical Nitrile and Polyisoprene Chemical Company (USMCC). USMCC is the only chemical plant in the U.S. currently producing both NBR nitrile and polyisoprene. Based in Honea Path, South Carolina, USMCC's chemical capacity make USMGC's supply chains 100% made-in-America. This secure supply chain and exclusive production commitments of raw supply provide stable growth and profitability to expand U.S. Medical Chemical Company's capability in South Carolina and future USMGC joint venture expansions. In operation for over 34 years, USMCC employs a long-tenured team of chemists and engineers who devote significant resources to research and development, making innovation central to a commitment to chemical production that advances better customer and environmental outcomes.
